BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

CellProthera and SKGH Forge Alliance to Advance CD34+ Cell Therapy for Ischemic Diseases in Japan

CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announced a new memorandum of understanding with Shonan Kamakur...

December 13, 2024 | News

Asahi Kasei Pharma Expands Global Reach with Exclusive Anti-CX3CR1 Antibody License

Asahi Kasei Pharma has taken another significant step toward becoming a leading global specialty pharmaceutical company by entering an exclusive license ag...

December 12, 2024 | News

GHIT Fund and WHO Strengthen Partnership to Combat Neglected Tropical Diseases

The Global Health Innovative Technology (GHIT) Fund and the World Health Organization (WHO) have signed a memorandum of understanding (MoU) to furthe...

December 11, 2024 | News

Ono Pharmaceutical Partners with Congruence Therapeutics to Advance Oncology Drug Discovery

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; "Ono") announced that it has entered into a drug discove...

December 09, 2024 | News

GE HealthCare to Acquire Full Ownership of Nihon Medi-Physics in Japan, Strengthening Leadership in Molecular Imaging

GE HealthCare to acquire 50% stake from Sumitomo Chemical to assume full ownership of NMP, subject to regulatory approvals As part of GE HealthC...

December 02, 2024 | News

Eisai and Biogen Japan Partner with NCNP for APOE Genetic Testing in Alzheimer’s Research

Eisai Co., Ltd. and Biogen Japan Ltd. announced that Eisai has entered into a research collaboration agreement with the National Center of Neurology and Ps...

November 27, 2024 | News

GC Biopharma and Novel Pharma Dose First US Patient in Pioneering Clinical Trial for Sanfilippo Syndrome Type A

GC Biopharma and Novel Pharma announced that the first patient in the US has been dosed in multinational clinical trial with 'GC1130A', an innovative new d...

November 26, 2024 | News

NTT and Olympus Showcase Breakthrough in Cloud-Based Endoscopy with IOWN APN Technology

NTT Corporation (TSE: 9432; “NTT”) and Olympus Corporation (TSE: 7733; “Olympus”) have successfully demonstrated the world’s ...

November 22, 2024 | News

Eisai Launches Rozebalamin® in Japan, Offering New Hope for ALS Patients

Eisai Co., Ltd. announced that the amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection25 mg” (mecobalamin) has ...

November 21, 2024 | News

Kura Oncology and Kyowa Kirin Forge $1.5 Billion Global Partnership for Ziftomenib in AML Across U.S., Japan, and International Markets

Kura to receive a $330 million upfront payment and up to $1.2 billion in total milestone payments, including $420 million in ...

November 21, 2024 | News

Singleron Biotechnologies Partners with TOMY Digital Biology to Expand Single Cell Analysis Solutions in Japan

Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with TOMY Digital Biology Co., Ltd. Unde...

November 20, 2024 | News

Nxera Pharma Secures $3.5M Milestone as Centessa Pharmaceuticals Launches Phase 2 Trial of ORX750 for Sleep Disorders

Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – notes t...

November 14, 2024 | News

Japan’s GHIT Fund Invests JPY 578 Million to Advance Diagnostics and Treatments for Neglected Tropical Diseases and Malaria

The Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 578 million (USD 4.0 million) in four projects ai...

November 07, 2024 | News

Inocras and Summit Pharmaceuticals Ink MOU to Transform Genomic Medicine in Japan

Inocras Inc. and Summit Pharmaceuticals International Corporation (“SPI”) signed an MOU (Memorandum of understanding) to jointly ex...

November 06, 2024 | News

Stay Connected